ITGB3 and non-small cell lung carcinoma: In the analysis of our NSCLC patient cohort, we found significant enrichment of these combinatorial markers on the CD61+ TILs compared to the CD61− TILs (Fig. 5f), therefore suggesting that the TILs subset is likely immune reactive within the tumor microenvironment.